Doug Chapman

836 citations
16 papers · 366 indexed · h-index 11
Topics
Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers)HIV Research and Treatment (5 papers)HIV/AIDS drug development and treatment (5 papers)
Partner nations
United StatesBrazilItaly

In The Last Decade

Doug Chapman

16 papers receiving 354 citations

Peers

Doug Chapman
Comparison fields: 5 of 52
  • Virology 188
  • Infectious Diseases 153
  • Molecular Biology 105
  • Surgery 62
  • Epidemiology 60
Replace O. Lambotte with:
O. Lambotte France
Schinella Ra United States
Nurith Vardinon Israel
Guglielmo Bruno Italy
A. Aronstam United Kingdom
Eitan Halper‐Stromberg United States
Elisa Gabanti Italy
Karol Serwin Poland
Amrit Singh United States
Ilona Tóth United States
Doug Chapman relative to O. Lambotte France O. Lambotte's profile →
Citations per field
00.5×
O. Lambotte · 1×
Citations per year

Countries citing papers authored by Doug Chapman

Since Specialization
Citations

This map shows the geographic impact of Doug Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doug Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doug Chapman more than expected).

Fields of papers citing papers by Doug Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doug Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doug Chapman. The network helps show where Doug Chapman may publish in the future.

Co-authorship network of co-authors of Doug Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Doug Chapman. A scholar is included among the top collaborators of Doug Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doug Chapman. Doug Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 2
2 1
3 16
4 1
5 15
6 8
7 11
8 10
9 2
10 14
11 24
12 15
13 35
14 119
15
Gastroesophageal reflux disease in children older than two years of age.
16
16 77

About Doug Chapman

Doug Chapman is a scholar working on Virology, Nephrology and Rheumatology, having authored 16 papers that have together received 366 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), HIV Research and Treatment (5 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Virology (188 citations), Infectious Diseases (153 citations) and Internal Medicine (13 citations). Doug Chapman has collaborated with scholars based in United States, Brazil and Italy. Frequent co-authors include C.C. Evans, Jayvant Heera, Hernán Valdez, Winnie Dong, Luke C. Swenson, Ian James, Marilyn Lewis, Conan K. Woods, P. Richard Harrigan and Mark A. Jensen. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026